H1B Report
Side-by-side comparison

Duke University Health System vs WIPRO LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Duke University Health System
NCRank #FEIN 56-2070036
Entity B
WIPRO LIMITED
NJRank #6FEIN 98-0154401

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDuke University Health SystemWIPRO LIMITED
Total filings28572,392
Certified %83.51%91.61%
Denied %7.72%0.37%
Withdrawn %2.11%1.37%
Cert-withdrawn %6.67%6.64%
Rank#6
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateNCNJ

Outcomes — Duke University Health System

DOL case-status mix.

Outcome breakdown: Certified 83.5%, Cert-withdrawn 6.7%, Withdrawn 2.1%, Denied 7.7%
Outcome breakdown
OutcomeShare
Certified83.5%
Cert-withdrawn6.7%
Withdrawn2.1%
Denied7.7%
Certified83.5%
Cert-withdrawn6.7%
Withdrawn2.1%
Denied7.7%

Outcomes — WIPRO LIMITED

DOL case-status mix.

Outcome breakdown: Certified 91.6%, Cert-withdrawn 6.6%, Withdrawn 1.4%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Duke University Health System
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104
FY201120
FY201218
FY201322
FY201420
FY201520
FY201621
FY201714
FY201817
FY201910
FY20204
FY20217
FY20225
FY20236
FY202436
FY202542
FY202619
WIPRO LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103,039
FY20113,025
FY20127,031
FY20136,574
FY20148,104
FY201511,824
FY201610,254
FY20175,012
FY20186,067
FY20194,154
FY202094
FY2021128
FY202297
FY2023554
FY20242,296
FY20252,289
FY20261,850

Top 5 occupations — Duke University Health System

Top 5 occupations — WIPRO LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.